Weight Loss Peptides Tirzepatide CAS 2023788-19-2

Skelbimo nr. 298074, įdėtas 2025-04-21 · Perskaitė: 39

Skelbimas nebegalioja.

Tirzepatide uniquely activates both GIP and GLP- receptors, enhancing insulin secretion, suppressing glucagon release, and delaying gastric emptying. This dual action synergistically reduces appetite, promotes satiety, and improves metabolic functions, leading to significant weight loss and glycemic control

Kaina: 30 EUR